Feedback / Questions
BLR-200 - BLR Bio
https://www.prnewswire.com/news-releases/rosalind-franklin-university-helix-51-incubator-company-granted-fda-orphan-drug-designation-for-treatment-of-scleroderma-302113837.html
Apr 11, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next